Andere Kunden interessierten sich auch für
![Natural Cholinesterase Inhibitors - As Alzheimer's Therapeutics]( "Natural Cholinesterase Inhibitors - As Alzheimer's Therapeutics")
Natural Cholinesterase Inhibitors - As Alzheimer's Therapeutics29,99 €![Natürliche Cholinesterase-Inhibitoren - als Alzheimer-Therapeutika]( "Natürliche Cholinesterase-Inhibitoren - als Alzheimer-Therapeutika")
Natürliche Cholinesterase-Inhibitoren - als Alzheimer-Therapeutika43,90 €![Design, Synthesis and Evaluation of Small Molecules as ALK5 Inhibitors]( "Design, Synthesis and Evaluation of Small Molecules as ALK5 Inhibitors")
Design, Synthesis and Evaluation of Small Molecules as ALK5 Inhibitors26,99 €![Recent approaches for the design of phosphodiesterase inhibitors]( "Recent approaches for the design of phosphodiesterase inhibitors")
Recent approaches for the design of phosphodiesterase inhibitors36,99 €![Quinoline Derivatives as Potential Antiamnesic Agents]( "Quinoline Derivatives as Potential Antiamnesic Agents")
Quinoline Derivatives as Potential Antiamnesic Agents32,99 €![Computaional Design and Evaluation of Antibacterial agents]( "Computaional Design and Evaluation of Antibacterial agents")
Computaional Design and Evaluation of Antibacterial agents46,99 €![Comparative Evaluation of Marketed Formulation of Antiparkinson Agents]( "Comparative Evaluation of Marketed Formulation of Antiparkinson Agents")
Comparative Evaluation of Marketed Formulation of Antiparkinson Agents36,99 €
Alzheimer's disease (AD) is a slowly progressive devasting neurodegenerative disorder of the central nervous system characterized by the accumulation of beta-amyloid proteins and the selective loss of cholinergic neurons in the brain. Generally, the drugs used, clinically to treat AD increases the acetylcholine level by inhibiting the metabolism of acetylcholinesterase (AChE). On the basis of the above-reported work and with the enthusiasm to discover and established a new lead molecule to treat AD, some new Schiff bases of p-amino benzoic acid and semicarbazones of 4-aminopyridine were synthesized. All the compounds were synthesized, purified, and characterized by state of art techniques. These compounds were then evaluated against anti-amnesic, cognition-enhancing, and anticholinesterase activity through their respective in-vitro and in-vivo models.